Entrada Therapeutics Inc.

NASDAQ: TRDA · Real-Time Price · USD
8.04
-0.20 (-2.43%)
At close: Jun 04, 2025, 3:40 PM

Entrada Therapeutics Revenue

Entrada Therapeutics reported an annual revenue of $210.78M, reflecting a 63.38% growth. For the quarter ending March 31, 2025, Entrada Therapeutics generated $20.56M in revenue.
Revenue (ttm)
$210.78M
Revenue Growth
63.38%
Price / Sales Ratio
3.06
Revenue / Employee
$1.15M
Employees
183
Market Cap
304.96M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.